Search Results 1361-1370 of 3922 for Solid

  1. Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease - Mayo Clinic

    Solid organ transplantation history. Autosomal dominant or recessive polycystic kidney disease. Known renovascular disease. Kidney failure (hemodialysis ...

  2. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

    All patients must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version (v) 1.1; measurable disease is defined ...

  3. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

    Single solid organ recipient (kidney only). ABO identical to the donor. ABO compatible pairs that are not identical (e.g., ABO-O donor to ABO-A recipient) ...

  4. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    ... Solid Tumors (RECIST) criteria 1.1, with radiologic scans within 21 days of day 1, cycle 1; Any number of prior therapies as long as patients have adequate ...

  5. Tumor cell PD-L1 may mediate sensitivity to chemotherapy in colorectal cancer treatment - Mayo Clinic News Network

    "We have identified a mechanism by which absent or low levels of tumor cell PD-L1, which is commonly found in solid tumors, can confer resistance to ...

  6. Publications - Harmeet Malhi, M.B.B.S. - Mayo Clinic

    2023 22nd International Conference on Solid-State Sensors, Actuators and Microsystems, Transducers 2023. 2023; 1982-5; Tang H, Li J, Zinker B, Boehm S, Mauer ...

  7. Face transplant - Mayo Clinic

    Smoking and solid organ transplantation. American Journal of Medicine. 2019; doi:10.1016/j.amjmed.2018.11.005. Related. News from Mayo Clinic. (VIDEO) Derek's ...

  8. Senescence in Chronic Kidney Disease - Clinical Trials

    Solid organ transplantation. Autosomal dominant or recessive polycystic kidney disease. Known renovascular disease. Pregnancy. Active immunosuppression ...

  9. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

    ... Solid Tumors (RECIST) target lesions, unless there are no other lesions accessible; Microbiology Susceptibility Subcategory (MSS) tumor as documented by ...

  10. Neuroblastoma Clinical Trials - Mayo Clinic Research

    ... solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have ... This phase II trial is studying the side effects and how well cixutumumab works in ...